Changes in cerebrospinal fluid biomarkers in human herpesvirus-6-associated acute encephalopathy/febrile seizures

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Tanuma, Naoyuki ^a,b   Miyata, Rie ^b   Nakajima, Keisuke ^b   Okumura, Akihisa ^c   Kubota, Masaya ^d   Hamano, Shin Ichiro ^e   Hayashi, Masaharu ^b  

^a Fuchu Medical Center for the Disabled   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; HEXANOYL LYSINE ADDUCT; INTERLEUKIN 10; INTERLEUKIN 6; NORPHENAZONE; TAU PROTEIN; UNCLASSIFIED DRUG; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE; PHENAZONE; PHENYLMETHYLPYRAZOLONE;

ACUTE BRAIN DISEASE; ARTICLE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEBRILE CONVULSION; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6 ASSOCIATED ENCEPHALOPATHY; HUMAN HERPESVIRUS 6 COMPLEX FEBRILE CONVULSION; MALE; MEDICAL EXAMINATION; OXIDATIVE STRESS; PRIORITY JOURNAL; ADOLESCENT; ANALOGS AND DERIVATIVES; METABOLISM; PATHOGENICITY; PHYSIOLOGY; ROSEOLOVIRUS INFECTIONS; SEIZURES, FEBRILE; VIROLOGY; YOUNG ADULT;

HUMAN HERPESVIRUS 6;

ADOLESCENT; ANTIPYRINE; BIOLOGICAL MARKERS; CHILD; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; MALE; ROSEOLOVIRUS INFECTIONS; SEIZURES, FEBRILE; YOUNG ADULT;

EID: 84932139969     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/564091     Document Type: Article

References (23)

1. J. Takanashi, H. Oba, A. J. Barkovich et al., "Diffusion MRI abnormalities after prolonged febrile seizures with encephalopathy", Neurology, vol. 66, no. 9, pp. 1304-1309, 2006.
2. J.-I. Takanashi, "Two newly proposed infectious encephalitis/encephalopathy syndromes", Brain and Development, vol. 31, no. 7, pp. 521-528, 2009.
3. A. Hoshino, M. Saitoh, A. Oka et al., "Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes", Brain and Development, vol. 34, no. 5, pp. 337-343, 2012.
4. M. Mizuguchi, "Overview of acute encephalitis and encephalopathy", Nippon Rinsho. Japanese Journal of Clinical Medicine, vol. 69, no. 3, pp. 391-398, 2011.
5. M. Hayashi, "Oxidative stress in developmental brain disorders", Neuropathology, vol. 29, no. 1, pp. 1-8, 2009.
6. J. Emerit, M. Edeas, and F. Bricaire, "Neurodegenerative diseases and oxidative stress", Biomedicine and Pharmacotherapy, vol. 58, no. 1, pp. 39-46, 2004.
7. K. Dasuri, L. Zhang, and J. N. Keller, "Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis", Free Radical Biology and Medicine, vol. 62, pp. 170-185, 2013.
8. M. Hayashi, N. Arai, J. Satoh et al., "Neurodegenerative mechanisms in subacute sclerosing panencephalitis", Journal of Child Neurology, vol. 17, no. 10, pp. 725-730, 2002.
9. M. Hayashi, M. Itoh, S. Araki et al., "Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders", Journal of Neuropathology & Experimental Neurology, vol. 60, no. 4, pp. 350-356, 2001.
10. M. Hayashi, S. Araki, J. Kohyama, K. Shioda, and R. Fukatsu, "Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome", Brain and Development, vol. 27, no. 1, pp. 34-38, 2005.
11. M. Hayashi, S. Araki, N. Arai et al., "Oxidative stress and disturbed glutamate transport in spinal muscular atrophy", Brain and Development, vol. 24, no. 8, pp. 770-775, 2002.
12. E. Otomo, H. Tohgi, K. Kogure et al., "Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: Randomized, placebo-controlled, double-blind study at multicenters", Cerebrovascular Diseases, vol. 15, no. 3, pp. 222-229, 2003.
13. B. J. Lee, Y. Egi, K. van Leyen, E. H. Lo, and K. Arai, "Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro", Brain Research, vol. 1307, pp. 22-27, 2010.
14. Y. Kitagawa, "Edaravone in acute ischemic stroke", Internal Medicine, vol. 45, no. 5, pp. 225-226, 2006.
15. Y. Higashi, "Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress", Expert Opinion on Pharmacotherapy, vol. 10, no. 2, pp. 323-331, 2009.
16. T. Valyi-Nagy and T. S. Dermody, "Role of oxidative damage in the pathogenesis of viral infections of the nervous system", Histology and Histopathology, vol. 20, no. 3, pp. 957-967, 2005.
17. T. Akaike, "Role of free radicals in viral pathogenesis and mutation", Reviews in Medical Virology, vol. 11, no. 2, pp. 87-101, 2001.
18. M. Fukuda, H. Yamauchi, H. Yamamoto et al., "The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels", Brain & Development, vol. 30, no. 2, pp. 131-136, 2008.
19. N. Tanuma, R. Miyata, S. Kumada et al., "The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion", Brain and Development, vol. 32, no. 6, pp. 435-439, 2010.
20. M. Öst, K. Nylén, L. Csajbok et al., "Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury", Neurology, vol. 67, no. 9, pp. 1600-1604, 2006.
21. T. Itoh, T. Satou, S. Nishida et al., "Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats", Neurochemical Research, vol. 35, no. 2, pp. 348-355, 2010.
22. M. Ohta, Y. Higashi, T. Yawata et al., "Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury", Brain Research, vol. 1490, pp. 184-192, 2013.
23. T. Satoh and S. A. Lipton, "Redox regulation of neuronal survival mediated by electrophilic compounds", Trends in Neurosciences, vol. 30, no. 1, pp. 37-45, 2007.